Two Unique Cases of Peritoneal Carcinomatosis Following Robotic Assisted Radical Prostatectomy
Journal Title: Journal of Urological Surgery - Year 2019, Vol 6, Issue 2
Abstract
We present two cases of peritoneal carcinomatosis following robotic assisted laparoscopic radical prostatectomy for prostate cancer. The first case is unique in that the carcinomatosis was found incidentally during a transperitoneal procedure for another malignancy. The patient did not possess high risk, adverse features and he experienced a 3-year period during which the prostate-specific antigen was undetectable. Our second case is unique in that, even though the patient had high risk disease, his margins were negative. It is possible that the transperitoneal nature of the surgeries may have contributed to the development of the metastases seen in these cases.
Authors and Affiliations
Jacob Baber, Tara McLaughlin, Joseph Wagner, Anoop Meraney
Keywords
Related Articles
- EP ID EP49003
- DOI 10.4274/jus.galenos.2018.2446
- Views 311
- Downloads 0
Insights into the Management of Overactive Bladder: What Difference Can Mirabegron Make?
Oral pharmacotherapy constitutes second-line treatment for overactive bladder (OAB) after lifestyle modifications, bladder retraining, and pelvic floor muscle exercises. Antimuscarinics have an established role in the tr...
Re: Low-intensity Shockwave Therapy for Erectile Dysfunction in Kidney Transplants Recipients. A Prospective, Randomized, Double Blinded, Sham-Controlled Study with Evaluation By Penile Doppler Ultrasonography
No summary
Comparison of Efficacy and Safety of Isolated Single Different Calyx Accesses in Percutaneous Nephrolithotomy
Objective: We aimed to compare the safety and efficacy of upper, middle and lower calyx accesses obtained as isolated and single access in percutaneous nephrolithotomy (PCNL) operation which is performed for treating ren...
Interpreting a Radical Prostatectomy Report
Worldwide, clinically detected prostate cancer is the second most common malignancy, with an estimated 1.1 million new cases in 2012. Standard active treatments for prostate cancer include radiotherapy and/or radical pro...
Bacillus Calmette-Guerin Increases Base Excision Repair in Bladder Cancer Cells
Objective: Most patients with non-muscle-invasive bladder cancer (NMIBC) do not respond to intravesical Bacillus Calmette-Guerin (BCG) immunotherapy and have high risk of NMIBC recurrence and progression. In addition to...